Results 41 to 50 of about 2,828,467 (301)
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani +7 more
wiley +1 more source
Background As person centred care (PCC) is being implemented globally, higher educational institutions (HEI) have begun to play a crucial part in enabling this transition. In Sweden, however, the delivery of PCC is inconsistently implemented in medicine,
A Jonnergård +5 more
doaj +1 more source
Developing a proxy version of the Adult social care outcome toolkit (ASCOT)
Background Social care-related quality of life is a key outcome indicator used in the evaluation of social care interventions and policy. It is not, however, always possible to collect quality of life data by self-report even with adaptations for people ...
Stacey Rand +3 more
doaj +1 more source
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben +4 more
wiley +1 more source
Edward T. Person Korean War collection [DIGITAL CONTENT]
This collection contains an oral history interview with Edward T.
Person, Edward T., 1927-2012
core +1 more source
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk +10 more
wiley +1 more source
Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin +17 more
wiley +1 more source
Erfolg als Professionalitätsmerkmal?
Zusammenfassung Der vorliegende Artikel beschäftigt sich mit dem Anspruch an Kursleiterinnen und Kursleiter, das berufliche Handeln bzw. die eigenen Lehrerfahrungen zu reflektieren.
Lisa David
doaj +1 more source
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann +8 more
wiley +1 more source
HSE National Facilitator Development Programme: enabling cultures of person-centred care and practice [PDF]
The HSE Corporate Plan 2021-2024i is committed to developing an organisational culture that is built on “shared values, beliefs and assumptions about how people behave and interact, how decisions are made and how activities are carried out”. This culture
National Quality Improvement Team
core

